The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...

Only about 5% of people with type 2 diabetes will achieve remission. A new study has found a combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet provides higher rates ...

Nearly half of people with type 2 diabetes are deficient in important vitamins and minerals, according to a new meta-analysis ... is linked to the use of the medication metformin, says Bridges.

A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...